Search - tctmd.com

Displaying 341 - 360 of 1502

Sort: Relevancy | Date

Presentation EuroPCR 2016

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Presenter: Josep Rod?s-Cabau

May 19, 2016

Presentation EuroPCR 2016

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Presenter: Christoph Naber

May 19, 2016

Presentation EuroPCR 2016

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

Presenter: Robert-Jan van Geuns

May 18, 2016

Presentation EuroPCR 2016

A Randomised Comparison Between Drug-Eluting Balloon and Conventional Balloon Angioplasty for Lesions in The Penile Artery in Patients With Erectile Dysfunction: The PEFECT-4 Study

Presenter: Tzung-Dau Wang

May 18, 2016

Presentation

Drug-Coated Balloon for Revascularization of Infrapopliteal Arteries

Presenter: Salvatore Cassese

April 28, 2016

Presentation

PCI in Patients With Insulin-Treated andNon-Insulin-Treated Diabetes Mellitus

Presenter: Sripal Bangalore

April 22, 2016

Presentation Fellows 2016

Stent Thrombosis and Restenosis

Presenter: William A. Gray, Ajay J. Kirtane

April 16, 2016

Presentation Fellows 2016

Drug-Eluting Stents: Past, Present, and Future

Presenter: Gregg Stone

April 15, 2016

Presentation ACC 2016

Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial

Presenter: Gregg W. Stone

April 03, 2016

Presentation

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

Presenter: Sripal Bangalore

March 29, 2016

Presentation

1-Year Outcomes With Absorb BVS: Patient-Level, Pooled Meta-Analysis

Presenter: Gregg Stone

March 29, 2016

Presentation

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

Presenter: Carlos Haiek

March 14, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How I Optimize Stent Implantation

Presenter: Jeffrey W. Moses

March 11, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Use Imaging to Optimize and Understand BRS

Presenter: Alexandre Abizaid

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

Role of OCT in Evaluation and treatment of In Stent Restenosis

Presenter: Andrew Lituchy

March 10, 2016

Presentation Intravascular Coronary Imaging and Physiology 2016

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Presenter: Ajay J. Kirtane

March 10, 2016

Presentation

Is BMS Implantation Still Justifiable in High Bleeding Risk Patients Undergoing PCI?

Presenter: Sara Ariotti

March 07, 2016

Presentation

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Presenter: Pil Hyung Lee

March 03, 2016

Presentation

Cardiovascular Risk of Prior Stent Implantation Among Patients Undergoing Noncardiac Surgery

Presenter: Karim D. Mahmoud

February 29, 2016

Presentation

Bioresorbable Coronary Scaffold Thrombosis

Presenter: S. Puricel

February 22, 2016

Advertisement

Sealing Moderate Coronary Saphenous Vein Graft Lesions with Drug-Eluting Stents as a New Approach to Reducing Cardiac Events The VELETI II Randomized Trial

Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a LEADERS FREE ACS substudy

Effect of DAPT Termination at 12 Months on Very Late scaffold thrombosis in regular clinical practice: Data of a regional collaboration

A Randomised Comparison Between Drug-Eluting Balloon and Conventional Balloon Angioplasty for Lesions in The Penile Artery in Patients With Erectile Dysfunction: The PEFECT-4 Study

Drug-Coated Balloon for Revascularization of Infrapopliteal Arteries

PCI in Patients With Insulin-Treated andNon-Insulin-Treated Diabetes Mellitus

Stent Thrombosis and Restenosis

Drug-Eluting Stents: Past, Present, and Future

Outcomes of the ABSORB Bioresorbable Vascular Scaffold in Very Small and Not Very Small Coronary Arteries: The ABSORB III randomized trial

Outcomes with Bioresorbable Vascular Scaffolds versus Everolimus-Eluting Stent

1-Year Outcomes With Absorb BVS: Patient-Level, Pooled Meta-Analysis

Second- vs First-Generation DES in Multivessel Disease With Left Main Stenosis

How I Optimize Stent Implantation

Use Imaging to Optimize and Understand BRS

Role of OCT in Evaluation and treatment of In Stent Restenosis

How (and Why) Do I Assess Causes of Stent Thrombosis and Restenosis?

Is BMS Implantation Still Justifiable in High Bleeding Risk Patients Undergoing PCI?

Successful Recanalization of Native Coronary CTO Is Not Associated With Improved Long-Term Survival

Cardiovascular Risk of Prior Stent Implantation Among Patients Undergoing Noncardiac Surgery

Bioresorbable Coronary Scaffold Thrombosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content